BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25

Group 1 - The Board of Directors of BD has declared a quarterly dividend of $1.04 per common share, with an annual dividend rate of$4.16 per share [1] - BD has repurchased $750 million in stock to date in fiscal 2025 and has authorized the repurchase of up to 10 million additional shares [2] - The company is one of the largest global medical technology firms, focusing on improving medical discovery, diagnostics, and care delivery [3] Group 2 - BD employs over 70,000 individuals and is committed to enhancing the safety and efficiency of healthcare delivery [3] - The company collaborates with organizations worldwide to tackle significant global health challenges [3] - BD aims to improve outcomes, lower costs, increase efficiencies, and expand access to healthcare through innovative technology and solutions [3]